Found: 5
Select item for more details and to access through your institution.
The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant Melanoma.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 2, p. 237, doi. 10.3390/cells12020237
- By:
- Publication type:
- Article
Doxorubicin-Induced TrkAIII Activation: A Selection Mechanism for Resistant Dormant Neuroblastoma Cells.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 18, p. N.PAG, doi. 10.3390/ijms231810895
- By:
- Publication type:
- Article
Molecular Characterization and Inhibition of a Novel Stress-Induced Mitochondrial Protecting Role for Misfolded TrkAIII in Human SH-SY5Y Neuroblastoma Cells.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 10, p. 5475, doi. 10.3390/ijms25105475
- By:
- Publication type:
- Article
A Study of Alternative TrkA Splicing Identifies TrkAIII as a Novel Potentially Targetable Participant in PitNET Progression.
- Published in:
- Biology (2079-7737), 2024, v. 13, n. 3, p. 171, doi. 10.3390/biology13030171
- By:
- Publication type:
- Article
Nutraceutical Preventative and Therapeutic Potential in Neuroblastoma: From Pregnancy to Early Childhood.
- Published in:
- Life (2075-1729), 2022, v. 12, n. 11, p. 1762, doi. 10.3390/life12111762
- By:
- Publication type:
- Article